PreprintbioRxivPublished
A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma
Regional connection
Verified Author affiliations on the Crossref record name Fox Chase Cancer Center, University of Pennsylvania, The Wistar Institute, with Temple Health linked by the institution reference. Affiliation source
Publication record
- Type
- Preprint
- Venue
- bioRxiv
- Published
- Topic
- Disease research
- PubMed ID
- 42856439
- PubMed Central ID
- PMC13648573
- Open access
- Yes, free to read
- Added to directory
- Source checked